Much of this growth can be traced to North Carolina's emergence as a center for the production and manufacture of therapeutics and vaccines.
The industry's growth in the state has been buoyed by an infrastructure of universities, non-profit organizations and service providers adept at launching, attracting and supporting life science businesses.